Media and News

PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery” at New York Biotechnology Association (NYBA) Annual Meeting in New York City, Marriot Marquis, Times Square, April 19-20 2010.

PharmaNova, Inc. to Present on “Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery” at New York Biotechnology Association (NYBA) Annual Meeting in New York City, Marriot Marquis, Times Square, April 19-20 2010.

 PharmaNova, Inc. of Victor, NY announced that PharmaNova Inc will be presenting at the NYBA 2010 Annual Meeting in New York City at the Marriot Marquis Times Square on April 19-20 2010.  The presentation is entitled Nanoparticle Formulations to Enhance Ophthalmic Drug Delivery”.  The presentation describes how PharmaNova’s platform nanoparticle technology, NovaSperse℠, has the potential to overcome many of the challenges to the effective and targeted delivery of drugs to the eye.

NYBA’s annual meetings consistently draw some 700 CEOs, senior executives, investors and prominent scientists from the biotechnology business communities in New York State, the Northeast, and the national and international biotech arenas.

 For more information on this event visit NYBA at: http://www.nyba.org/meeting/annualMeeting

About PharmaNova

PharmaNova Inc. is a privately held pharmaceutical company.  Our product candidates are derived from the re‐positioning and enhancement of known drugs using our proprietary NovaSperse℠ nanoparticle technology platform. We address low risk, fast to market products in areas of clear medical need and generate revenue from partnering and licensing strategies with commercialization partners and clients worldwide. PharmaNova also conducts contractual formulation development work applying NovaSperse technology to client‐owned products and compounds to support new product development or the extended life cycle management of existing products.  PharmaNova has other new product candidates in various stages in its development pipeline.   Our focus is on the development of novel, improved nanoparticle formulations of ophthalmic and anti-infective products.


Members of the media or for further information, please contact Tom Parker, Vice President Commercial Affairs:
tom.parker@pharmanovaco.com, (1) 585 413-4721.



« Back to Media

Member of the media wishing to learn more about Pharmanova should contact:
Rafael Larramendi, President | ral@rochester.rr.com | (585) 919 -9649.